Bupa Platinum consultant
Fee assured
Verified account
Open Referral network
Specialises in
Offers
- Face-to-face consultations
- Video and telephone consultations
About me
Professor Ramon Andrade De Mello, MD, MBA, PhD, FACP, is a highly distinguished Consultant Medical Oncologist providing world-class, precision cancer care for Bupa members. Practising at premier private locations, including The Blackheath Hospital and Harley Street, he specialises in the diagnosis and systemic treatment of Gastrointestinal (GI), Lung, and Breast cancers.
As a fully recognised Bupa provider, Professor De Mello is dedicated to offering rapid access to private consultations, advanced molecular diagnostics, and cutting-edge therapies tailored to each patient's unique tumour biology.
Current NHS Leadership & Academic Roles
Demonstrating his standing within the UK healthcare system, Professor De Mello is a Senior Substantive Consultant Medical Oncologist at the Kent Oncology Centre (Maidstone and Tunbridge Wells NHS Trust) and Darent Valley Hospital in Dartford.
Operating at the absolute forefront of modern oncology, he bridges the gap between sophisticated translational research and clinical practice as a Visiting Professor at the Kent and Medway Medical School (University of Kent). He ensures his patients have access to the latest evidence-based protocols, novel immunotherapies, and targeted treatments.
Elite Clinical Background: Oxford & The Royal Marsden
Professor De Mello's exceptional clinical acumen is built upon a foundation of elite medical practice within the UK's most prestigious institutions. His distinguished career includes serving as a Consultant Medical Oncologist at Oxford University Hospitals (OUH) and as a Senior Clinical Researcher within the Department of Oncology at the University of Oxford. He further refined his specialist expertise early in his career by completing a prestigious Fellowship at The Royal Marsden Hospital in London, a global landmark in oncology excellence.
A Compassionate, Patient-Centred Approach
Recognising that a cancer diagnosis is life-changing, Professor De Mello combines his rigorous scientific background with a deeply human, compassionate approach. He is dedicated to explaining complex molecular biology and treatment pathways in clear, accessible language, empowering Bupa patients and their families to make informed, confident decisions throughout their entire care journey.
He is a prolific international researcher, a Fellow of the Royal Society of Medicine, and an active Faculty Member and Preceptor for global societies such as ASCO and ESMO.
For more information on research and publications, please visit: www.ramondemello.co.uk
Areas of interest
Gastrointestinal Cancers: Colorectal, Gastric, Oesophageal, and Pancreatic;
Lung Cancer: Non-Small Cell (NSCLC) and Small Cell (SCLC);
Breast Cancer: Comprehensive systemic therapies and targeted treatments.
Precision Oncology, Biomarkers & Liquid Biopsies;
Targeted Therapies & Novel Immunotherapies;
Complex Cases & Academic Second Opinions;
Medical secretaries
About me
External resources
Current NHS consultant posts held
Professor De Mello serves as a Consultant Medical Oncologist at the Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust.
He holds clinical duties at both Darent Valley Hospital in Dartford and Maidstone Hospital.
Research interests
Professor De Mello's research is deeply focused on precision oncology, immuno-oncology, and targeted therapies.
He actively investigates the role of biomarkers in advanced non-small cell lung cancer, gastrointestinal malignancies, and breast cancer to ensure treatments are specifically tailored to individual tumour genetic profiles.
His scientific work spans cancer epigenetics and synthetic lethality, effectively bridging the gap between sophisticated laboratory discoveries and bedside patient care.
Personal interests
Outside of his rigorous clinical and academic commitments, Professor De Mello is an avid golfer and an active member of the Royal Blackheath Golf Club.
He also maintains a keen interest in the technical specifications and engineering of high-end automobiles.
A Fellow of the Royal Society of Medicine, he enjoys participating in academic and social events at historic London institutions, including the Oxford and Cambridge Club.
(Additional) Languages spoken
Publications
A prolific international researcher and author, Professor De Mello serves as the Editor-in-Chief of the highly regarded 'Medical Oncology Compendium' (Elsevier, 2025).
He is also the Editor-in-Chief of the 'International Manual of Oncology Practice' (Springer).
He has authored numerous core medical book chapters and published extensive peer-reviewed articles in top-tier global medical journals, including The Lancet Oncology, Journal of Clinical Oncology, and Annals of Oncology.
Courses offered to GPs
As a Visiting Professor at the Kent and Medway Medical School, Professor De Mello offers free, CPD-accredited oncology seminars for GPs. Key topics include 'Red Flags in GI & Lung Cancers', 'Immunotherapy in Primary Care', and 'Personalised Oncology & Molecular Profiling'. He is available for both virtual (Teams/Zoom) and in-person lunch-and-learn sessions across London and Kent.
My outcomes
Outcomes (checked and approved by medical professional body)
Please click on this link if you would like to see information about this
healthcare professional’s performance compared to their peers, as published by
their medical professional body.
https://www.doctify.com/uk/specialist/ramon-andrade-de-mello
Outcomes (self-reported)
As a Consultant Medical Oncologist, my outcomes focus on the safety, efficacy, and quality of life achieved during systemic anti-cancer treatments (chemotherapy, immunotherapy, and targeted therapies).
Patient Safety & Toxicity: Safety is my absolute priority. Through meticulous pre-treatment education and proactive symptom control, unplanned hospital admissions due to treatment toxicities are kept to a strict minimum.
Multidisciplinary Excellence: I maintain a 100% compliance rate in reviewing all new and complex cancer diagnoses at Multidisciplinary Team (MDT) meetings, ensuring every treatment plan is consensus-driven and meets the absolute gold standard of care.
Evidence-Based Efficacy: My protocols strictly adhere to the latest ESMO, ASCO, and NICE guidelines. By incorporating advanced genomic profiling and liquid biopsies, I ensure patients receive highly targeted therapies designed to maximise progression-free and overall survival.
Satisfaction & Quality of Life: I consistently receive exceptional patient feedback. I emphasize shared decision-making, explaining complex molecular biology in clear, accessible language. My ultimate goal is to treat the cancer while preserving the patient's dignity, autonomy, and quality of life throughout their journey.
My qualifications & training
Qualifications
- MD (Doctor of Medicine)
Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil, and Faculty of Medicine, Univeristy of Lisbon, Portugal 2004
- PhD in Molecular Oncology
Faculty of Medicine University of Porto, Portugal 2013
- Fellow Membership Title
American College of Medicine 2017
- Master of Business Administration in Executive Management of Clinics, Hospital, and Health Industries
Getulio Vargas Foundation, Campus Paulista, São Paulo, Brazil 2022
- Certification in Medical Oncology
European Society for Medical Oncology 2014
- Board Certification in Medical Oncology
ACSS - Health Ministry, Lisbon, Portugal 2015
- Board Certification in Medical Oncology
Brazilian Society of Cancerology (SBC) / Brazilian Medical Association (AMB) 2017
- PG Diploma in Medicine and Molecular Oncology
University of Porto, Portugal 2009
Additional training
- Clinical Fellwoship in Lung Cancer
The Royal Marsden Hospital NHS Trust 2013
- Speciality Training in Medical Oncology
Portuguese Oncology Institute, Porto, Portugal 2015
GMC registration
Reference number 7436909
Professional bodies (positions held - last 3 yrs)
- Member of the Annual Meeting Auditor Group (2025 – Present) and Preceptor for the Virtual Mentorship Programme (2020 – Present).
American Society of Clinical Oncology (ASCO) 2025
- Faculty Member of the College of the European School of Oncology (ESCO) and Member of the Gastrointestinal Cancer Advisory Board (2020 – Present).
European School of Oncology (ESO) 2020
- Vice-President (2024 – Present) and former Head of the Medical Oncology Section (2021 – 2024)
Brazilian Society of Cancerology (SBC): 2024
- Fellow Member (2021 – Present).
Royal Society of Medicine (RSM), London, UK 2021
Details of entry to specialist register
- CCT in Medical Oncology
, 2016
Affiliations / memberships
Fellow: Royal Society of Medicine (RSM, UK) & American College of Physicians (FACP).
Vice-President: Brazilian Society of Cancerology (SBC).
Faculty: European School of Oncology (ESCO).
Full Member: American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), British Medical Association (BMA, UK) and Portuguese Society for Oncology (SPO).
My private practice
Practice hours
Practice
Day
Hours
Appt Bookings
- 40-42 Lee Terrace Blackheath LONDON SE3 9UD
- Tuesday
- 08:00
- 09:00
- 07458 197677
- 40-42 Lee Terrace Blackheath LONDON SE3 9UD
- Thursday
- 08:00
- 09:00
- 07458 197677
- 40-42 Lee Terrace Blackheath LONDON SE3 9UD
- Friday
- 17:30
- 18:30
- 07458 197677
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs
in line with Department of Health, GMC and appropriate professional bodies
guidelines.
Other ways of contacting me
I can be contacted directly using Skype. My
Skype ID is: Ramon.mello
Launch
Website
